Form 4 Filing: Kayyem Jon Faiz Buys $500K of $INBX

INSIDER PURCHASE

⚡ MATERIALITY: 6/10

corporate issuer

Inhibrx Biosciences, Inc.

Ticker: $INBX

Transaction Value

$500K

Price/Share: $100.00

transaction date

2026-09-16

Shares: 5,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kayyem Jon Faiz, holds the title of Director at Inhibrx Biosciences, Inc..

On 2026-09-16, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $100.00 per share, resulting in a total market-relevant value of $500K.

Executive Summary Summary

Kayyem Jon Faiz (Director) bought $500K of $INBX

Post-Transaction Position: 429,360 shares

SEC Accession No: 0001366268-26-000006 (CIK: 1366268)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$INBX Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$INBX News Coverage